Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:alsoKnownAs |
gptkb:CPI-0610
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Constellation_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
KT-333
|
| gptkbp:intendedUse |
treatment of cancer
|
| gptkbp:mechanismOfAction |
BET inhibitor
|
| gptkbp:target |
gptkb:bromodomain_and_extraterminal_domain_proteins
|
| gptkbp:bfsParent |
gptkb:Kymera_Therapeutics
|
| gptkbp:bfsLayer |
7
|